DISCLAIMER

DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.

Friday, January 22, 2010

GlaxoSmithKline to publish Malaria reasearch report

GlaxoSmithKline, a manufacturer of pharmacy products, has revealed that it will open up its database containing thousands of potential anti-malaria compounds.

The information, which has remained confidential until now, will be shared with the world's scientists as they work to develop a cure for the mosquito-transmitted condition.

In addition to the data on 13,500 molecules, the organisation stated that it will also establish a not-for-profit foundation in Europe with a starting investment of $8 million (4.91 million pounds).

This, it added, will work towards funding research and establishing greater knowledge-sharing between scientists.

"GSK has the capability to make a difference and a genuine appetite to change the landscape of healthcare for the world's poorest people," stated chief executive of the organisation Andrew Witty.

According to the World Health Organization, malaria is caused by plasmodium which are transmitted via mosquitoes and multiply in the liver, before attacking the red blood cells of those infected.

Stephen Pierce is offering his book "Make Real Money on the Internet" absolutely free!!!!!! Get your copy today!!

No comments: